Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

ROPIVACAINE HYDROCHLORIDE INJECTION 2 MG

ROPIVACAINE HYDROCHLORIDE : 2 MG · DIN 02408589 · TEVA CANADA LIMITED

Health Canada status: CANCELLED PRE MARKET

What is ROPIVACAINE HYDROCHLORIDE INJECTION?

ROPIVACAINE HYDROCHLORIDE INJECTION 2 MG contains ROPIVACAINE HYDROCHLORIDE : 2 MG. It is listed in the Health Canada Drug Product Database under DIN 02408589, held by TEVA CANADA LIMITED, supplied as SOLUTION for EPIDURAL ; BLOCK/INFILTRATION administration. Health Canada currently lists it as cancelled pre market, status dated 29-Jul-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02408589
Brand nameROPIVACAINE HYDROCHLORIDE INJECTION
Generic / active ingredientROPIVACAINE HYDROCHLORIDE : 2 MG
ManufacturerTEVA CANADA LIMITED
Strength2 MG
Dosage formSOLUTION
Route of administrationEPIDURAL ; BLOCK/INFILTRATION
ScheduleEthical
ATC codeN01BB09 ROPIVACAINE
AHFS class72:00.00
BiosimilarNo
Health Canada statusCANCELLED PRE MARKET
Status date29-Jul-2021

Is ROPIVACAINE in shortage in Canada?

A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by FRESENIUS KABI CANADA LTD, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.

Check availability for ROPIVACAINE HYDROCHLORIDE INJECTION

What can be used instead?

Other Canadian products sharing ATC code N01BB09 ROPIVACAINE. 6 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
NAROPIN10 MGSOLUTIONASPEN PHARMACARE CANADA INC.MARKETEDDIN 02229418
NAROPIN2 MGSOLUTIONASPEN PHARMACARE CANADA INC.MARKETEDDIN 02229411
NAROPIN5 MGSOLUTIONASPEN PHARMACARE CANADA INC.MARKETEDDIN 02229415
ROPIVACAINE HYDROCHLORIDE INJECTION, USP10 MGSOLUTIONFRESENIUS KABI CANADA LTDMARKETEDDIN 02439409
ROPIVACAINE HYDROCHLORIDE INJECTION, USP2 MGSOLUTIONFRESENIUS KABI CANADA LTDMARKETEDDIN 02439379
ROPIVACAINE HYDROCHLORIDE INJECTION, USP5 MGSOLUTIONFRESENIUS KABI CANADA LTDMARKETEDDIN 02439387
NAROPIN INJ 7.5MG/ML7.5 MGLIQUIDASTRAZENECA CANADA INCCANCELLED POST MARKETDIN 02229416
ROPIVACAINE HYDROCHLORIDE INJECTION USP10 MGSOLUTIONPFIZER CANADA ULCCANCELLED POST MARKETDIN 02347830
ROPIVACAINE HYDROCHLORIDE INJECTION USP2 MGSOLUTIONPFIZER CANADA ULCCANCELLED PRE MARKETDIN 02403285
ROPIVACAINE HYDROCHLORIDE INJECTION USP5 MGSOLUTIONPFIZER CANADA ULCCANCELLED POST MARKETDIN 02347822

Who else supplies ROPIVACAINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. ROPIVACAINE appears in 49 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Health Canada Drug Product Database (DPD), DIN 02408589. Last reviewed 2026-09-09. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.